ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC31310-5mg |
|
935840-13-4 |
H3 receptor antagonist 1
|
0 | C20H28F2N2O | |
GC31310-1mg |
|
935840-13-4 |
H3 receptor antagonist 1
|
0 | C20H28F2N2O | |
GC31309-100mg |
|
2471-70-7 |
6-Methoxy-2-naphthoic acid (Naproxen impurity O)
|
0 | C12H10O3 | |
GC31309-10mM(1mLinDMSO) |
|
2471-70-7 |
6-Methoxy-2-naphthoic acid (Naproxen impurity O)
|
0 | C12H10O3 | |
GC31308-20mg |
|
184653-84-7 |
Carabersat
|
0 | C20H20FNO4 | |
GC31308-10mg |
|
184653-84-7 |
Carabersat
|
0 | C20H20FNO4 | |
GC31308-5mg |
|
184653-84-7 |
Carabersat
|
0 | C20H20FNO4 | |
GC31308-1mg |
|
184653-84-7 |
Carabersat
|
0 | C20H20FNO4 | |
GC31307-100mg |
|
816-66-0 |
4-Methyl-2-oxopentanoic acid
|
0 | C6H10O3 | |
GC31306-10mg |
|
890037-68-0 |
CB1 antagonist 1
|
0 | C26H22Cl2N4 | |
GC31306-5mg |
|
890037-68-0 |
CB1 antagonist 1
|
0 | C26H22Cl2N4 | |
GC31306-1mg |
|
890037-68-0 |
CB1 antagonist 1
|
0 | C26H22Cl2N4 | |
GC31305-10mg |
|
225526-17-0 |
Piperidinylaminomethyl Trifluoromethyl Cyclic Ether Compound 1
|
0 | C24H29F3N2O2 | |
GC31305-5mg |
|
225526-17-0 |
Piperidinylaminomethyl Trifluoromethyl Cyclic Ether Compound 1
|
0 | C24H29F3N2O2 | |
GC31305-1mg |
|
225526-17-0 |
Piperidinylaminomethyl Trifluoromethyl Cyclic Ether Compound 1
|
0 | C24H29F3N2O2 | |
GC31303-100mg |
|
11070-73-8 |
Insulin(cattle) (Insulin from bovine pancreas)
|
0 | C254H377N65O75S6 | |
GC31303-50mg |
|
11070-73-8 |
Insulin(cattle) (Insulin from bovine pancreas)
|
0 | C254H377N65O75S6 | |
GC31303-25mg |
|
11070-73-8 |
Insulin(cattle) (Insulin from bovine pancreas)
|
0 | C254H377N65O75S6 | |
GC31303-10mg |
|
11070-73-8 |
Insulin(cattle) (Insulin from bovine pancreas)
|
0 | C254H377N65O75S6 | |
GC31302-10mg |
|
632355-68-1 |
NHE3-IN-1
|
0 | C12H10ClN3S | |